Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy. [electronic resource]
Producer: 20070306Description: 496-501 p. digitalISSN:- 0008-543X
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- blood
- Breast Neoplasms -- blood
- Carcinoma, Ductal, Breast -- blood
- Carcinoma, Lobular -- blood
- Cyclophosphamide -- administration & dosage
- Epirubicin -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Humans
- Kinetics
- Middle Aged
- Neoadjuvant Therapy
- Prognosis
- Prospective Studies
- Receptor, ErbB-2 -- blood
- Trastuzumab
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.